Company Registration No. SC688172 (Scotland)
KELTIC PHARMA LIMITED
Annual Report and Statement of Accounts
For the Period from 01 January 2023 to 31 December 2023

KELTIC PHARMA LIMITED

Annual report and statement of accounts for the period ending 31/12/2023

KELTIC PHARMA LIMITED

Financial statement for the period ended 31/12/2023

Company Information

1 Statutory Information
Company Number SC688172
Registered Office NO 11 THE SQUARE UNIVERSITY AVENUE
GLASGOW
LANARKSHIRE
G12 8QQ
2 Directors
Directors who held office during the period were:
Andrew George JAMIESON   
Graeme MILLIGAN   
Angus Murray ROSS   
Andrew Bruno TOBIN   
3 Principal Activity
The principal activity of the company is that of medical research and development.
4 Employees
Average number of employees, including directors, during the year was as follows:
2023 0
2022 0

KELTIC PHARMA LIMITED

Financial statement for the period ended 31/12/2023

Statement of Financial Position

2023 2022
£ £
Called up share capital not paid 1 1
Fixed Assets - -
Current Assets 390 -
Creditors: amounts falling due within one year (390) -
Net Current Assets - -
Total assets less current liabilities 1 1
Creditors: amounts falling due after one year - -
Net Assets 1 1
Capital and reserves 1 1
For the period ending 31/12/2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Approved by the Board on 17 September 2024
Andrew Tobin
Company Registration No. SC688172